As with other disease states, biomarkers that can provide value across diagnosis, prognosis, and treatment response, have ...

Social isolation significantly increases the risk of mortality in patients with chronic obstructive pulmonary disease (COPD), ...

Patients with locally advanced hepatocellular carcinoma (HCC) who achieve a complete response after locoregional therapy and ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

This multiyear follow-up of more than 3300 patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) who ...

Attendees of the centennial American Heart Association (AHA) conference commend the meeting's ability to bring together diverse, interdisciplinary perspectives from across the globe.

The US has not gotten a grade above a C+ since 2013, as the preterm birth rate has gone up almost a whole percentage point in ...

On Friday, President-elect Donald Trump announced his nominations to lead the CDC, for FDA Commissioner, and for Surgeon ...

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of ...

A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world ...